Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: A systematic review and meta-analysis

Ultrasound in Obstetrics and Gynecology

Volumn 46, Issue 6, 2015, Pages 650-658

  Grande, M ^a   Jansen, F A R ^b   Blumenfeld, Y J ^c   Fisher, A ^d   Odibo, A O ^e   Haak, M C ^b   Borrell, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Elliot Health System   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

copy number variants; cystic hygroma; genomic microarray; increased nuchal translucency; prenatal diagnosis

Indexed keywords

CHROMOSOME 22; CHROMOSOME DUPLICATION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; CYSTIC LYMPHANGIOMA; DIGEORGE SYNDROME; ECHOGRAPHY; FEMALE; FETUS DEVELOPMENT; FETUS DISEASE; FIRST TRIMESTER PREGNANCY; GENETICS; GENOMICS; HUMAN; KARYOTYPE; KARYOTYPING; META ANALYSIS; MULTIPLE MALFORMATION SYNDROME; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PROCEDURES; TISSUE MICROARRAY;

ABNORMALITIES, MULTIPLE; CHROMOSOME DUPLICATION; CHROMOSOMES, HUMAN, PAIR 22; COMPARATIVE GENOMIC HYBRIDIZATION; DIGEORGE SYNDROME; DNA COPY NUMBER VARIATIONS; FEMALE; FETAL DEVELOPMENT; FETAL DISEASES; GENOMICS; HUMANS; KARYOTYPE; KARYOTYPING; LYMPHANGIOMA, CYSTIC; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TISSUE ARRAY ANALYSIS;

EID: 84949526240     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14880     Document Type: Article

References (46)

1. Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH,. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192: 1005-1021.
2. Zadeh N, Hudgins L, Norton ME,. Nuchal translucency measurement in fetuses with spinal muscular atrophy. Prenat Diagn 2011; 31: 327-330.
3. Barone C, Bianca S,. Further evidence of no association between spinal muscular atrophy and increased nuchal translucency. Fetal Diagn Ther 2013; 33: 65-68.
4. Mangione R, Guyon F, Taine L, Wen ZQ, Roux D, Vergnaud A, Maugey-Laulom B, Horovitz J, Saura R,. Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency. Fetal Diagn Ther 2001; 16: 360-363.
5. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH,. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001; 18: 9-17.
6. Senat MV, De Keersmaecker B, Audibert F, Montcharmont G, Frydman R, Ville Y,. Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn 2002; 22: 345-349.
7. Bilardo CM, Müller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK,. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol 2007; 30: 11-18.
8. Mula R, Goncé A, Bennásar M, Arigita M, Meler E, Nadal A, Sánchez A, Botet F, Borrell A,. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age. Ultrasound Obstet Gynecol 2012; 39: 34-41.
9. Pergament E, Alamillo C, Sak K, Fiddler M,. Genetic assessment following increased nuchal translucency and normal karyotype. Prenat Diagn 2011; 31: 307-310.
10. Oneda B, Baldinger R, Reissmann R, Reshetnikova I, Krejci P, Masood R, Ochsenbein-Kölble N, Bartholdi D, Steindl K, Morotti D, Faranda M, Baumer A, Asadollahi R, Joset P, Niedrist D, Breymann C, Hebisch G, Hüsler M, Mueller R, Prentl E, Wisser J, Zimmermann R, Rauch A,. High-resolution chromosomal microarrays in prenatal diagnosis significantly increase diagnostic power. Prenat Diagn 2014; 34: 525-533.
11. Brady PD, Delle Chiaie B, Christenhusz G, Dierickx K, Van Den Bogaert K, Menten B, Janssens S, Defoort P, Roets E, Sleurs E, Keymolen K, De Catte L, Deprest J, de Ravel T, Van Esch H, Fryns JP, Devriendt K, Vermeesch JR,. A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genet Med 2014; 16: 469-476.
12. Evangelidou P, Alexandrou A, Moutafi M, Ioannides M, Antoniou P, Koumbaris G, Kallikas I, Velissariou V, Sismani C, Patsalis PC,. Implementation of high resolution whole genome array CGH in the prenatal clinical setting: advantages, challenges, and review of the literature. Biomed Res Int 2013; 2013: 346762.
13. Hillman SC, McMullan DJ, Hall G, Togneri FS, James N, Maher EJ, Meller CH, Williams D, Wapner RJ, Maher ER, Kilby MD,. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013; 41: 610-620.
14. Scott F, Murphy K, Carey L, Greville W, Mansfield N, Barahona P, Robertson R, McLennan A,. Prenatal diagnosis using combined quantitative fluorescent polymerase chain reaction and array comparative genomic hybridization analysis as a first-line test: results from over 1000 consecutive cases. Ultrasound Obstet Gynecol 2013; 41: 500-507.
15. Fiorentino F, Napoletano S, Caiazzo F, Sessa M, Bono S, Spizzichino L, Gordon A, Nuccitelli A, Rizzo G, Baldi M,. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities. Eur J Hum Genet 2013; 21: 725-730.
16. Yatsenko SA, Davis S, Hendrix NW, Surti U, Emery S, Canavan T, Speer P, Hill L, Clemens M, Rajkovic A,. Application of chromosomal microarray in the evaluation of abnormal prenatal findings. Clin Genet 2013; 84: 47-54.
17. Faas BH, Feenstra I, Eggink AJ, Kooper AJ, Pfundt R, van Vugt JM, de Leeuw N,. Non-targeted whole genome 250 K SNP array analysis as replacement for karyotyping in fetuses with structural ultrasound anomalies: evaluation of a one-year experience. Prenat Diagn 2012; 32: 362-370.
18. Armengol L, Nevado J, Serra-Juhé C, Plaja A, Mediano C, García-Santiago FA, García-Aragonés M, Villa O, Mansilla E, Preciado C, Fernández L, Ángeles Mori M, García-Pérez L, Lapunzina PD, Pérez-Jurado LA,. Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Hum Genet 2012; 131: 513-523.
19. Srebniak MI, Boter M, Oudesluijs GO, Cohen-Overbeek T, Govaerts LC, Diderich KE, Oegema R, Knapen MF, van de Laar IM, Joosten M, Van Opstal D, Galjaard RJ,. Genomic SNP array as a gold standard for prenatal diagnosis of foetal ultrasound abnormalities. Mol Cytogenet 2012; 5: 14.
20. Tyreman M, Abbott KM, Willatt LR, Nash R, Lees C, Whittaker J, Simonic I,. High resolution array analysis: diagnosing pregnancies with abnormal ultrasound findings. J Med Genet 2009; 46: 531-541.
21. Charan P, Woodrow N, Walker SP, Ganesamoorthy D, McGillivray G, Palma-Dias R,. High-resolution microarray in the assessment of fetal anomalies detected by ultrasound. Aust N Z J Obstet Gynaecol 2014; 54: 46-52.
22. Vestergaard EM, Christensen R, Petersen OB, Vogel I,. Prenatal diagnosis: array comparative genomic hybridization in fetuses with abnormal sonographic findings. Acta Obstet Gynecol Scand 2013; 92: 762-768.
23. Ganesamoorthy D, Bruno DL, McGillivray G, Norris F, White SM, Adroub S, Amor DJ, Yeung A, Oertel R, Pertile MD, Ngo C, Arvaj AR, Walker S, Charan P, Palma-Dias R, Woodrow N, Slater HR,. Meeting the challenge of interpreting high-resolution single nucleotide polymorphism array data in prenatal diagnosis: does increased diagnostic power outweigh the dilemma of rare variants? BJOG 2013; 120: 594-606.
24. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, Klugman S, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L,. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012; 367: 2175-2184.
25. Lee CN, Lin SY, Lin CH, Shih JC, Lin TH, Su YN,. Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: a cohort study of 3171 pregnancies. BJOG 2012; 119: 614-625.
26. D'Amours G, Kibar Z, Mathonnet G, Fetni R, Tihy F, Désilets V, Nizard S, Michaud JL, Lemyre E,. Whole-genome array CGH identifies pathogenic copy number variations in fetuses with major malformations and a normal karyotype. Clin Genet 2012; 81: 128-141.
27. Evangelidou P, Sismani C, Ioannides M, Christodoulou C, Koumbaris G, Kallikas I, Georgiou I, Velissariou V, Patsalis PC,. Clinical application of whole-genome array CGH during prenatal diagnosis: Study of 25 selected pregnancies with abnormal ultrasound findings or apparently balanced structural aberrations. Mol Cytogenet 2010; 3: 24.
28. Maya I, Davidov B, Gershovitz L, Zalzstein Y, Taub E, Coppinger J, Shaffer LG, Shohat M,. Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. Prenat Diagn 2010; 30: 1131-1137.
29. Vialard F, Molina Gomes D, Leroy B, Quarello E, Escalona A, Le Sciellour C, Serazin V, Roume J, Ville Y, de Mazancourt P, Selva J,. Array comparative genomic hybridization in prenatal diagnosis: another experience. Fetal Diagn Ther 2009; 25: 277-284.
30. Van den Veyver IB, Patel A, Shaw CA, Pursley AN, Kang SH, Simovich MJ, Ward PA, Darilek S, Johnson A, Neill SE, Bi W, White LD, Eng CM, Lupski JR, Cheung SW, Beaudet AL,. Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn 2009; 29: 29-39.
31. Kleeman L, Bianchi DW, Shaffer LG, Rorem E, Cowan J, Craigo SD, Tighiouart H, Wilkins-Haug LE,. Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype. Prenat Diagn 2009; 29: 1213-1217.
32. Donnelly JC, Platt LD, Rebarber A, Zachary J, Grobman WA, Wapner RJ,. Association of copy number variants with specific ultrasonographically detected fetal anomalies. Obstet Gynecol 2014; 124: 83-90.
33. Huang J, Poon LC, Akolekar R, Choy KW, Leung TY, Nicolaides KH,. Is high fetal nuchal translucency associated with submicroscopic chromosomal abnormalities on array CGH? Ultrasound Obstet Gynecol 2014; 43: 620-624.
34. Lund IC, Christensen R, Petersen OB, Vogel I, Vestergaard EM,. Chromosomal microarray in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 2015; 45: 95-100
35. Rooryck C, Toutain J, Cailley D, Bouron J, Horovitz J, Lacombe D, Arveiler B, Saura R,. Prenatal diagnosis using array-CGH: a French experience. Eur J Med Genet 2013; 56: 341-345.
36. Shaffer LG, Rosenfeld JA, Dabell MP, Coppinger J, Bandholz AM, Ellison JW, Ravnan JB, Torchia BS, Ballif BC, Fisher AJ,. Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound. Prenat Diagn 2012; 32: 986-995.
37. Leung TY, Vogel I, Lau TK, Chong W, Hyett JA, Petersen OB, Choy KW,. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol 2011; 38: 314-319.
38. Law LW, Lau TK, Fung TY, Leung TY, Wang CC, Choy KW,. De novo 16p13.11 microdeletion identified by high-resolution array CGH in a fetus with increased nuchal translucency. BJOG 2009; 116: 339-343.
39. Choy KW, To KF, Chan AW, Lau TK, Leung TY,. Second-trimester detection of Mowat-Wilson syndrome using comparative genomic hybridization microarray testing. Obstet Gynecol 2010; 115: 462-465.
40. Graesslin O, Derniaux E, Alanio E, Gaillard D, Vitry F, Quéreux C, Ducarme G,. Characteristics and outcome of fetal cystic hygroma diagnosed in the first trimester. Acta Obstet Gynecol Scand 2007; 86: 1442-1446.
41. Malone FD, Ball RH, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Canick JA, Bianchi DW, D'Alton ME,;, FASTER Trial Research Consortium,. First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol 2005; 106: 288-294.
42. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-536.
43. de Wit MC, Srebniak MI, Govaerts LC, Van Opstal D, Galjaard RJ, Go AT,. Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature. Ultrasound Obstet Gynecol 2014; 43: 139-146.
44. Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH,. Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol 2006; 107: 6-10.
45. Jansen FA, Blumenfeld YJ, Fisher A, Cobben JM, Odibo AO, Borrell A, Haak MC,. Array comparative genomic hybridization and fetal congenital heart defects-a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 27-35.
46. Yobb TM, Somerville MJ, Willatt L, Firth HV, Harrison K, MacKenzie J, Gallo N, Morrow BE, Shaffer LG, Babcock M, Chernos J, Bernier F, Sprysak K, Christiansen J, Haase S, Elyas B, Lilley M, Bamforth S, McDermid HE,. Microduplication and triplication of 22q11.2: a highly variable syndrome. Am J Hum Genet 2005; 76: 865-876.